NEW YORK (GenomeWeb) – NantHealth announced today that it has signed a distribution agreement for its cancer molecular profiling service GPS Cancer with Asia Genomics.

Under the terms of the deal, Asia Genomics will distribute GPS Cancer to physicians in Singapore, Malaysia, Thailand, Vietnam, and the Philippines. Additional terms of the agreement were not disclosed.

GPS Cancer integrates whole-genome sequencing, whole-transcriptome sequencing, and quantitative proteomics to provide oncologists with a molecular profile of a patient's specific cancer.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.